FDA advisory committee votes against expanded indication for Pacira's Exparel

Pacira Pharmaceuticals Inc. (NASDAQ:PCRX) said FDA’s Anesthetic and Analgesic Drug Products Advisory Committee voted 6-4 against approval of a resubmitted sNDA for

Read the full 225 word article

User Sign In